by Clinical Neuropsychologist | Thursday, May 23, 2024 | Dementia
We elicited Vietnamese Americans’ perspectives on culturally appropriate recruitment into a new research registry: Collaborative Approach for Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs) Research and Education (CARE). Three focus groups were...
by Clinical Neuropsychologist | Thursday, May 23, 2024 | Dementia
The prevalence of mild and major neurocognitive disorders (NCDs), also referred to as mild cognitive impairment and dementia, is rising globally. The prevention of NCDs is a major global public health interest. We sought to synthesize the literature on potentially...
by Clinical Neuropsychologist | Wednesday, May 22, 2024 | Dementia
Abstract INTRODUCTION Evaluating whether genetic susceptibility modifies the impact of lifestyle-related factors on dementia is critical for prevention. METHODS We studied 5170 participants from a French cohort of older persons free of dementia at baseline and...
by Clinical Neuropsychologist | Wednesday, May 22, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | May 22, 2024 Wiley: Alzheimer’s & Dementia: Table...
by Clinical Neuropsychologist | Tuesday, May 21, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) pathology is defined by β-amyloid (Aβ) plaques and neurofibrillary tau, but Lewy bodies (LBs; 𝛼-synuclein aggregates) are a common co-pathology for which effective biomarkers are needed. METHODS A validated...
